The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Novartis
Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO1 to predict outcomes to anti-PD-1 in metastatic melanoma (MM).
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Genoptix
Research Funding - Incyte
 
Jennifer Bordeaux
Employment - Genoptix
Patents, Royalties, Other Intellectual Property - Genoptix (Inst)
 
Ju Young Kim
Employment - Genoptix
Patents, Royalties, Other Intellectual Property - Genoptix (Inst)
 
Christine Vaupel
Employment - Genoptix
Stock and Other Ownership Interests - Novartis
 
David L. Rimm
Stock and Other Ownership Interests - Metamark Genetics
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Cell Signaling Technology; Genentech
Consulting or Advisory Role - AstraZeneca; Bethyl Laboratories; Biocept; Bristol-Myers Squibb; Cernostics; Five Prime Therapeutics; Genoptix; Optra SCAN; Perkin Elmer
Research Funding - Cepheid; Gilead Sciences; Kolltan Pharmaceuticals; OncoPlex Diagnostics; Perkin Elmer; Pierre Fabre (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Ventana Medical Systems
 
Thai Huu Ho
No Relationships to Disclose
 
Richard Wayne Joseph
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Genoptix; Nektar
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Merck; Roche/Genentech (Inst); X4 Pharma (Inst)
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Honoraria - EMD Serono; Inovio Pharmaceuticals
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - patent relating to test for immunotherapy
 
Robert Martin Conry
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Elizabeth M Gaughan
No Relationships to Disclose
 
Anastasios Dimou
No Relationships to Disclose
 
Justin M. Balko
Research Funding - Incyte
Patents, Royalties, Other Intellectual Property - Patent on use of HLA-DR/MHC expression to predict response to immunotherapies
 
James William Smithy
Patents, Royalties, Other Intellectual Property - Yale University (Inst)
 
John S Witte
Consulting or Advisory Role - Genoptix
Expert Testimony - Pfizer
 
Svetlana B McKee
No Relationships to Disclose
 
Nicole Dominiak
No Relationships to Disclose
 
Bashar Dabbas
Employment - Genoptix
Leadership - Genoptix
Consulting or Advisory Role - Genoptix
Speakers' Bureau - Genoptix; Novartis
Travel, Accommodations, Expenses - Novartis
Other Relationship - Genoptix; Novartis
 
Jeff Hall
Employment - Genoptix
Stock and Other Ownership Interests - Bristol-Myers Squibb; Medtronic; Novartis
 
Naveen Dakappagari
Employment - Genoptix
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Genopitx (Inst)